Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Affymetrix, a provider of genetic analysis technologies to pharmaceutical, diagnostic and biotechnology companies, has named Frank Witney as the new president and CEO, effective 1 July 2011.
Subscribe to our email newsletter
Prior to joining Affymetrix, Witney worked as the president and CEO of Dionex
Before joining Dionex, Witney served as executive vice president and chief commercial officer of Affymetrix, following Affymetrix’s acquisition of Panomics, in December 2008.
Witney said he is pleased to be rejoining Affymetrix and he looks forward to working with the board of directors, executive team and Affymetrix’s employees to enhance the company’s position and accelerate its growth and success.